IDIQ task order
Active Awarded Last action
- Contract number
- 75F40125F19006
- Awardee
-
Tuvli LLC UEI LGYKTQFA4BR5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $6,143,392
Award facts
- Contract value 64% obligated
-
- $6,143,392.00 Current, with exercised options
- $9,622,404.00 Potential, with all options
- Completion date 66% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541512 Computer Systems Design Services
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $2,597,484 | |
| Exercise an Option | $519,498 | |
| Original award | $3,026,410 |
About this award
The Food and Drug Administration issued a delivery order to Tuvli LLC on November 6, 2024, with a ceiling value of $9,622,404 under a competitive 8(a) set-aside, with ultimate completion on October 31, 2027.
Tuvli LLC is an Alaskan Native Corporation-owned, minority-owned, and self-certified small disadvantaged business. The order is issued under an IDIQ task order vehicle. Place of performance is Silver Spring, Maryland.
Scope includes development and dissemination of education materials on rare disease drug development. Tuvli engaged Research Triangle Institute (RTI International) as a subcontractor for this effort, with RTI's award made November 13, 2025. Additional subcontractors include Take2 Consulting LLC (IT staffing services, August 1, 2025) and Idoxsolutions, Inc. (IT services support, July 30, 2025), supporting FDA's electronic submissions ingest modernization initiative.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Research Triangle Institute | $65,405 | |
| Take2 Consulting LLC | $232,599 | |
| Idoxsolutions, Inc. | $278,128 |
Quick answers
Who was awarded contract 75F40125F19006?
75F40125F19006 was awarded to Tuvli LLC by Food and Drug Administration (Department of Health and Human Services) on November 6, 2024.
How much is contract 75F40125F19006 worth?
The government has obligated $6,143,392 on 75F40125F19006. Its potential value, with all options, is $9,622,404.
Is contract 75F40125F19006 an order under another contract?
Yes. 75F40125F19006 is a delivery order under 75F40122D00025, an indefinite delivery contract.
Was contract 75F40125F19006 competed?
The extent of competition for 75F40125F19006 was full and open competition after exclusion of sources. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award